Source Natural Foods & Herbal Supplements Hits All-Time High, Outperforms Sensex in Past Year
Source Natural Foods & Herbal Supplements Ltd, a microcap company in the pharmaceuticals and drugs industry, has seen a surge in its stock price, reaching an all-time high on October 4th, 2024. Despite a recent trend reversal, the company has shown strong performance and positive moving averages, making it a company to watch in the stock market.
Source Natural Foods & Herbal Supplements Ltd, a microcap company in the pharmaceuticals and drugs industry, has been making headlines in the stock market recently. On October 4th, 2024, the company's stock price reached an all-time high, causing a stir among investors and analysts.
According to MarketsMOJO, a leading stock market analysis platform, the current recommendation for Source Natural Foods & Herbal Supplements is 'Hold'. This comes after the stock has shown a strong performance in the past year, with a 169.96% increase compared to the Sensex's 26.12% growth.
Despite the recent surge in stock price, Source Natural Foods & Herbal Supplements is still 3.43% away from its 52-week high of Rs 237.9. Today, the stock underperformed the sector by -3.25% and opened with a gap down of -5.11%. It also saw a trend reversal after 9 consecutive days of gains, with an intraday low of Rs 225.75.
However, the company's moving averages show a positive trend, with the stock trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong performance in the short and long term.
Source Natural Foods & Herbal Supplements is a microcap company, which means it has a market capitalization of less than $300 million. Despite its small size, the company has shown impressive growth in the past year, outperforming the Sensex by a significant margin.
In conclusion, Source Natural Foods & Herbal Supplements has been making waves in the stock market with its recent all-time high stock price. While the current recommendation is to hold, the company's strong performance and positive moving averages suggest a potential for future growth. Investors and analysts will be keeping a close eye on this microcap company in the pharmaceuticals and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
